Updated Jul 16, 2026
Knowles Julius has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $28K.

Julius Knowles appears in SEC filings as an individual associated with Keros Therapeutics, Inc. as of the filing date of 2026-06-05. Public biographical information about Knowles Knowles is not readily available, and there is no widely published record of his professional background, titles, or accomplishments beyond regulatory disclosures. The entry here reflects regulatory documentation rather than a detailed public profile.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-08 | KROS | Keros Therapeutics, Inc. | S — Open-market sale | 2.6K | $10.73 | $28K |
| 2026-06-05 | KROS | Keros Therapeutics, Inc. | A — Grant or award | 7.1K | $0.00 |
Julius Knowles appears in SEC filings as an individual associated with Keros Therapeutics, Inc. as of the filing date of 2026-06-05. Public biographical information about Knowles Knowles is not readily available, and there is no widely published record of his professional background, titles, or accomplishments beyond regulatory disclosures. The entry here reflects regulatory do…
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($28K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Knowles Julius profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.